PERTUZUMAB
UNII K16AIQ8CTM

Substance Identification & Data

This profile provides standardized clinical and technical data for Pertuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K16AIQ8CTM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 380610-27-5 and the RxNorm Concept ID (RxCUI) 1298944. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

K16AIQ8CTM

CAS Registry Number

380610-27-5

RxNorm Concept ID

1298944

Detailed Substance Profile

Preferred Name

PERTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

K16AIQ8CTM

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C38692

National Cancer Institute reference terminology for clinical and research data.

INN ID

8380

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OO-59

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pertuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PERTUZUMAB

PERTUZUMAB (GENETICAL RECOMBINATION)

PERTUZUMAB-DPZB

PERTUZUMAB-ZZXF

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER

PERTUZUMAB [INN]

PERTUZUMAB [JAN]

PERTUZUMAB [MART.]

PERTUZUMAB [MI]

PERTUZUMAB [PURPLE BOOK CDER]

PERTUZUMAB [USAN]

PERTUZUMAB [VANDF]

PERTUZUMAB [WHO-DD]

PERTUZUMAB BIOSIMILAR (CSPC PHARMA)

SYSA-1901 (PERTUZUMAB BIOSIMILAR)